Status:
TERMINATED
Impact of the Use of Zinc in the Prevention of Oral Mucositis in Pediatric Patients With Lymphoblastic Acute Leukemia.
Lead Sponsor:
National Institute of Pediatrics, Mexico
Collaborating Sponsors:
Hospital Infantil de Mexico Federico Gomez
Conditions:
Oral Mucositis
Eligibility:
All Genders
3-18 years
Phase:
NA
Brief Summary
Oral mucositis (OM) is a secondary complication of chemo/radiotherapy, which causes pain, dysphagia and predisposition to infections, being a frequent reason for hospitalization that may have an impac...
Detailed Description
Objective: To evaluate the impact of the use of zinc in the prevention, incidence and severity of oral mucositis in patients with acute lymphoblastic leukemia in chemotherapy (induction and consolidat...
Eligibility Criteria
Inclusion
- Patients aged 3 to 18 years
- Patients with recent diagnosis of ALL or relapse
- Pacientes who accept by informed consent to participate in the study.
Exclusion
- Patients with another disease or systemic condition in addition to ALL.
- Patients with Down syndrome
- Patients allergic to zinc or mannitol.
Key Trial Info
Start Date :
June 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04321850
Start Date
June 10 2019
End Date
July 30 2020
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marta M. Zapta Tarrés
México, Mexico, 04530